Celltrion Executive and Leadership Team

Younghwan Kim, the Division Chief Financial Officer at Celltrion, manages the company's financial health and strategic investment planning. Kim oversees all financial operations, including budgeting, forecasting, and capital allocation, ensuring resources are directed towards research, development, and manufacturing of biosimilar and innovative drugs. This critical role supports Celltrion's objective of making advanced therapeutics more accessible by optimizing financial performance and exploring new funding avenues. Younghwan Kim's financial acumen is essential for sustaining the company's growth and its commitment to providing affordable treatment options globally. The Division Chief Financial Officer also plays a key part in evaluating potential partnerships and acquisitions that align with Celltrion's long-term vision. By maintaining rigorous financial discipline, Kim ensures the company's capacity to innovate and expand its market presence.

Lee Seung Joon, the President at Celltrion, directs the overarching strategic vision and operational execution of the biopharmaceutical company. Joon oversees the development, manufacturing, and global commercialization of biosimilar and innovative drugs, focusing on expanding patient access to advanced therapeutics. This leadership position involves guiding research and development efforts to bring novel treatments to market and ensuring the efficient production of high-quality biosimilars. Lee Seung Joon is instrumental in fostering collaborations and partnerships that advance Celltrion's mission to provide more affordable treatment options worldwide. The President's role encompasses driving innovation, ensuring regulatory compliance, and maintaining the company's competitive edge in the global biopharmaceutical landscape. Joon's strategic direction supports Celltrion's commitment to improving global health outcomes through accessible, cutting-edge medicines.

Youngsup Han, the President, Celltrion (China), spearheads the company's strategic operations and market expansion within the vital Chinese region. Han directs the localized implementation of Celltrion's mission to provide accessible biosimilar and innovative drugs, adapting global strategies to meet regional healthcare needs. This role is critical for navigating the complexities of the Chinese pharmaceutical market, ensuring regulatory compliance, and fostering strong relationships with local healthcare stakeholders. Youngsup Han's leadership focuses on increasing patient access to Celltrion's advanced therapeutics by optimizing distribution channels and market penetration. The President, Celltrion (China) plays a key part in driving sales growth and establishing Celltrion as a trusted provider of high-quality biopharmaceuticals in China. Han's efforts directly contribute to Celltrion's global objective of making essential treatments more affordable and available.

Jiyun Seol, the Head Chief Marketing Officer, Operations Department at Celltrion, directs strategic market initiatives and operational execution. Overseeing the deployment of Celltrion's biosimilar and innovative drug portfolio, Seol ensures alignment with global market demands and patient access goals. This leadership role involves close collaboration with research and development teams to translate scientific advancements into commercially viable products. Jiyun Seol drives the operational framework necessary for bringing life-changing therapeutics to patients worldwide, focusing on efficient supply chain management and market penetration strategies. The Head Chief Marketing Officer, Operations Department is pivotal in expanding Celltrion's reach, particularly in regions requiring robust operational support for advanced biopharmaceuticals. By optimizing internal processes and external market engagement, Seol contributes directly to Celltrion's mission of providing affordable, high-quality treatments.

Dong Kim, the Chief Marketing Officer, Quality Assurance at Celltrion, leads initiatives that bridge product quality with market positioning. Kim ensures that Celltrion's commitment to high standards in biosimilar and innovative drug development is effectively communicated to global markets. This dual focus guarantees that products meet stringent regulatory requirements while also resonating with healthcare providers and patients seeking reliable, advanced therapeutics. Dong Kim's leadership is crucial in maintaining trust and credibility, supporting Celltrion's mission to increase access to affordable treatments. The Chief Marketing Officer, Quality Assurance oversees the strategic messaging around product efficacy and safety, reinforcing the company's reputation for excellence. By integrating quality assurance principles into marketing strategies, Kim drives market acceptance and supports the company's expansion into new therapeutic areas.